Data Sheet
The Changing Microbial Protein Market
Cobra produced its first protein product in 1995 and has since offered a range of development/cGMP services for mammalian and microbially derived therapeutic proteins, biosimilars, mAbs and fAbs for preclinical to commercial supply.
